Latest News.
ShanX Medtech to strengthen relationship with Erasmus MC
ShanX Medtech and the Erasmus Medical Center (Erasmus MC) have been working together towards the further development and validation of ShanX's antibiotic testing device. The cooperation has been strengthened with the Health Holland PPP Allowance through AMR-Global. AMR-Global is an international Public-Private Partnership that aims to combat Antimicrobial Resistance...
ShanX Medtech to receive the Brabant Startup Fund
Braventure is now supporting ShanX Medtech with the Brabant Startup Fund (BSF). BSF is an early stage investment tool for highly innovative companies in the region of Noord Brabant, The Netherlands. The innovation must contribute to solving social challenges and must strengthen technological growth in Brabant. Our innovation addresses...
ShanX Medtech is selected to join the Pole Position by Techleap
ShanX Medtech has been chosen to join the Pole Position alongside other impact-driven, high-potential Dutch startups that are working relentlessly to improve patient care by bringing much-needed innovations to the market. About Techleap: Techleap.nl helps quantify and accelerate the tech ecosystem of the Netherlands. Creating the optimal climate for tech...
ShanX Medtech a step closer to market with the Eurostars
Hundreds of millions of people suffer from Urinary Tract Infections (UTIs) every year worldwide. With the majority of UTIs stemming from a bacterial infection, the treatment thereof is straightforward: an antibiotic prescription. But for doctors quickly determining which antibiotic is effective for each patient is challenging. ShanX Medtech is...
ShanX Medtech receives the MIT feasibility study 2022
ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy. This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally...
Three entry level positions open
We are in the process of expanding our team and we are looking for the next team member that will join us in our adventures. More specifically, we are looking for three entry level team members from the field of microbiology (2x) and product development (microfluidics). Keep an eye...
ShanX Medtech receives support by the Leadership4SMEs
ShanX Medtech has become part of the Leadership4SMEs community, a community to accelerate IP-driven businesses. This community brings together more than 500 high potential European SMEs and start-ups. From the overall community, 15 start-ups and 15 SMEs with the potential to become success stories have been selected through 2...
ShanX Medtech at ECCMID 2022, Portugal
ShanX Medtech is joining the 32nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Lisbon, Portugal from April 23-26. Contact us at info@shanxmedtech.nl for a face-to-face introduction.
ShanX Medtech at the Health Valley, NL
Come meet us in Nijmegen! This year, we will be joining the Health Valley Event 2022 on March the 15th to the 17th in Nijmegen, The Netherlands. Not far from home, we are excited to join the conference with the DIGI B CUBE support, where we will showcase our...
ShanX Medtech at the SLAS2022 in Boston, USA
The Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition brings innovators for valuable networking, education and discovery. ShanX Medtech will attend the conference in Boston, MA in the US. The conference will be held from February 5th to February 9th, 2022. Contact us at info@shanxmedtech.nl for a...
Two leaders of ShanX Medtech are amongst the InspiringFifty Benelux+ 2022
Big day today! Today we celebrate diversity within the world of Deep Tech with both Dr. Sophia E. Shanko (CEO of ShanX Medtech) and Carmen van Vilsteren (Medtech serial entrepreneur and ShanX advisor) being named as part of the Inspiring Fifty Benelux+ 2022. InspiringFifty is a pan-European programme that aims...
ShanX Medtech and Omnigen BV awarded the MIT R&D grant
ShanX Medtech together with Omnigen BV are going to develop a fast diagnostic tool for testing of Urinary Tract Infections under the recently awarded MIT Zuid R&D grant by Stimulus Programmamanagemnt! The two parties bring complementary skills for the implementation of such an innovative project! This innovation is among the...
ShanX Medtech at the Hello Tomorrow Global Summit in Paris
Earlier this year we were recognized as Deep Tech Pioneers by Hello Tomorrow. This allows us to attend the Hello Tomorrow Investor Day and Global Summit in Paris on Dec. 1st - 3rd. The Global Summit welcomes prestigious scientists, entrepreneurs and brilliant minds to discuss, debate and share cutting-edge...
ShanX Medtech at the MEDICA fair in Düsseldorf
MEDICA is taking place in Düsseldorf on November 15-18, 2021. The event is a leading international trade fair, and it is a wonderful place to meet partners in exhibition halls. As such we will be attending the event. If you want to meet us and discover what we do...
ShanX Medtech is speaking at the MEDICA Healthcare Brokerage Event 2021
On the occasion of MEDICA 2021 (15 - 18 November 2021), the global No. 1 meeting place for the medical sector, ZENIT GmbH together with the Healthcare Sector Group of the Enterprise Europe Network are organizing the international Brokerage Event. ShanX Medtech is being given the opportunity to introduce...
ShanX Medtech recognized as a Deep Tech Pioneer by Hello Tomorrow
We are delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that we’ve been recognised by Hello Tomorrow as one the most promising technologies in deep tech to date. Over 4000 technologies were submitted from 115 countries, and ours was...
Founder and CEO, Sophia E. Shanko on the TOPX Summit on 22-23 September
Women are still underrepresented in high level positions even nowadays. Though there are more women than men in Europe only 16% of European startups are founded or co-founded by women. The TOPX Network aims to create a unique and valuable network for ambitious women in Life Sciences by supporting their...
ShanX Medtech is awarded the MIT feasibility study
ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy. This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally...
ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can determine fast antibiotic efficacy.
ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can quickly determine antibiotic efficacy. The DIGI-B-CUBE project has been awarded to accelerate the goal of personalized medicine that can eventually offer patients with fast and efficient treatment system. This project has received funding from...
ShanX Medtech at Innovation for Health 2020 in Rotterdam
ShanX Medtech will attend the Innovation for Health 2020 on February the 12th and 13th 2020 at the De Doelen ICC in Rotterdam!
ShanX Medtech is awarded a grant by the Metropoolregio Eindhoven
Antibiotic resistance is a public global health issue. Unnecessary and injudicious antibiotic use may contribute to the rise of antibiotic resistance. To tackle this use, regulating antibiotic administration is very important. The Metropool Regio Eindhoven is supporting ShanX Medtech in the development of an antibiotic efficiency testing device.
